A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Clinical trial NCT01774851 · TERMINATED
Trial details
- NCT number
- NCT01774851
- Sponsor
- Merrimack Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-07-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.